search
Back to results

Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue Inflammation

Primary Purpose

NAFLD

Status
Unknown status
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
overeating fat
overeating carbohydrate
Sponsored by
University of Helsinki
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for NAFLD focused on measuring NAFLD, insulin resistance, metabolic syndrome, de novo lipogenesis, overfeeding

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • BMI 27-35 kg/m2
  • Age 18-65 yrs

Exclusion Criteria:

  • type 1 or 2 diabetes
  • renal insufficiency
  • pre-existing liver or significant other disease other than NAFLD (i.e. autoimmune, viral or drug-induced liver disease)
  • excessive use of alcohol (over 20g/day)
  • pregnancy or lactation

Sites / Locations

  • Clinical studies: Biomedicum 2U, Tukholmankatu 8, 00290 Helsinki, Rooms 106b and 105bRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

High fat diet

High carbohydrate diet

Arm Description

Intervention: overeating high fat diet (1000 extra calories per day) for 3 weeks

Intervention: overeating high carbohydrate diet (1000 extra calories per day) for 3 weeks

Outcomes

Primary Outcome Measures

Liver fat content (1H-MRS) and intra-abdominal and subcutaneous fat (MRI)
De novo lipogenesis (DNL) and measurement of lipolysis
the rate of DNL and adipose tissue lipolysis is measured using doubly labeled water (DDW) and [1,1,2,3,3-2H5] glycerol

Secondary Outcome Measures

Analytical procedures
Laboratory tests including fasting glucose, insulin, C-peptide, liver enzymes, total, LDL and HDL cholesterol and TG concentrations PNPLA3 genotyping is performed also

Full Information

First Posted
May 5, 2014
Last Updated
May 6, 2014
Sponsor
University of Helsinki
search

1. Study Identification

Unique Protocol Identification Number
NCT02133144
Brief Title
Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue Inflammation
Official Title
Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue Inflammation
Study Type
Interventional

2. Study Status

Record Verification Date
May 2014
Overall Recruitment Status
Unknown status
Study Start Date
February 2014 (undefined)
Primary Completion Date
February 2015 (Anticipated)
Study Completion Date
June 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Helsinki

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
A. BACKGROUND Accumulation of fat in the liver due to non-alcoholic causes (NAFLD) is associated with hepatic insulin resistance, which impairs the ability of insulin to inhibit the production of glucose and VLDL . This leads to increases in serum glucose, insulin and triglyceride concentrations as well as hyperinsulinemia. Recent epidemiologic studies have shown that a major reason for the metabolic syndrome as well as the accompanying increased risk of cardiovascular disease and type 2 diabetes is overconsumption of simple sugars. The investigators have recently shown that overeating simple sugars (1000 extra calories/day, "CANDY" diet) increases liver fat content by 30% within 3 weeks (4), and recapitulates features of the metabolic syndrome such as hypertriglyceridemia and a low HDL cholesterol concentration. The fatty acids in intrahepatocellular triglycerides may originate from peripheral lipolysis, de novo lipogenesis, uptake of chylomicron remnants by the liver and from hepatic uptake of fatty acids released during intravascular hydrolysis of triglyceride-rich lipoproteins (the spillover pathway). A classic study using stable isotope methodology by the group of Elisabeth Parks showed that in subjects with NAFLD, the excess intrahepatocellular triglycerides originate from peripheral lipolysis and de novo lipogenesis. It is well-established that ingestion of a high carbohydrate as compared to high fat diet stimulates de novo lipogenesis in humans. Meta-analyses comparing isocaloric high fat and high carbohydrate diets have shown that high carbohydrate but not high fat diets increase increase serum triglycerides and lower HDL cholesterol. Since hypertriglyceridemia results from overproduction of VLDL from the liver, these data suggest the composition of the diet influences hepatic lipid metabolism. Whether this is because overfeeding fat leads to preferential deposition of fat in adipose tissue while high carbohydrate diets induce a relative greater increase in liver fat is unknown. There are no previous studies comparing effects of chronic overfeeding of fat as compared to carbohydrate on liver fat or and the sources of intrahepatic fatty acids. A common polymorphism in PNPLA3 at rs738409 (adiponutrin) gene is associated with a markedly increase liver fat content. This finding has been replicated in at least 20 studies across the world. The investigators have shown that PNPLA3 is regulated by the carbohydrate response element binding protein 1. Mice overexpressing the human I148M PNPLA3 variant in the liver exhibit an increase in liver triglycerides and cholesteryl esters on a high sucrose but not high fat diet. These data suggest that overfeeding a high carbohydrate as compared to a high fat diet may increase liver fat more in subjects carrying the I148M allele than in non-carriers. B. HYPOTHESIS The investigators hypothesize that overfeeding a high fat as compared to an isocaloric high carbohydrate diet influences the source of intrahepatocellular triglycerides. During a high fat diet, relatively more of intrahepatocellular triglycerides originate from peripheral lipolysis and less from DNL than during a high carbohydrate diet in the face of a similar increase in liver fat. It is also possible given the lack of previous overfeeding data comparing 2 different overfeeding diets that the high fat diet induces a smaller increase in liver fat than a high carbohydrate diet even in the face of an identical increase in caloric intake because a greater fraction of ingested fat is channeled to adipose tissue than the liver. The investigators also hypothesize that liver fat may increase more in carriers than non-carriers of the I148M variant in PNPLA3 during a high carbohydrate than a high fat diet. C. SPECIFIC AIMS The investigators wish to randomize, using the method of minimization (considers baseline age, BMI, gender, liver fat, PNPLA3 genotype) 40 non-diabetic subjects with NAFLD as determined by the non-invasive score developed in our laboratory or previous knowledge of liver fat content based on MRS to overeat either a high carbohydrate or high fat diet (1000 extra calories per day) for 3 weeks. Before and after the overfeeding diets, will measure liver fat content by 1H-MRS and the rate of adipose tissue lipolysis using doubly labeled water (DDW) and [1,1,2,3,3-2H5] glycerol as described in detail below. The investigators also wish to characterize glucose, insulin, fatty acid and triacylglyceride profiles before and while on the experimental diet. An adipose tissue biopsy is taken to determine whether expression of genes involved in lipogenesis or lipolysis, or those involved in adipose tissue inflammation change in response to overfeeding, and for measurement of LPL activity. After overfeeding, both groups will undergo weight loss to restore normal weight as described in our recent study. The metabolic study is repeated after weight loss.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
NAFLD
Keywords
NAFLD, insulin resistance, metabolic syndrome, de novo lipogenesis, overfeeding

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
High fat diet
Arm Type
Experimental
Arm Description
Intervention: overeating high fat diet (1000 extra calories per day) for 3 weeks
Arm Title
High carbohydrate diet
Arm Type
Experimental
Arm Description
Intervention: overeating high carbohydrate diet (1000 extra calories per day) for 3 weeks
Intervention Type
Behavioral
Intervention Name(s)
overeating fat
Intervention Type
Behavioral
Intervention Name(s)
overeating carbohydrate
Primary Outcome Measure Information:
Title
Liver fat content (1H-MRS) and intra-abdominal and subcutaneous fat (MRI)
Time Frame
3 weeks
Title
De novo lipogenesis (DNL) and measurement of lipolysis
Description
the rate of DNL and adipose tissue lipolysis is measured using doubly labeled water (DDW) and [1,1,2,3,3-2H5] glycerol
Time Frame
3 weeks
Secondary Outcome Measure Information:
Title
Analytical procedures
Description
Laboratory tests including fasting glucose, insulin, C-peptide, liver enzymes, total, LDL and HDL cholesterol and TG concentrations PNPLA3 genotyping is performed also
Time Frame
3 weeks
Other Pre-specified Outcome Measures:
Title
Biopsies and analysis of subcutaneus adipose tissue
Description
Needle biopsies of abdominal subcutaneus tissue will be taken for subsequent isolation of RNA for measurements of gene expression (by quantitative PCR). Fat cell size is also measured.
Time Frame
3 weeks
Title
Indirect calorimetry
Description
Indirect calorimetry is the method by which metabolic rate is estimated from measurements of oxygen (O2) consumption and carbon dioxide (CO2) production.
Time Frame
3 week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: BMI 27-35 kg/m2 Age 18-65 yrs Exclusion Criteria: type 1 or 2 diabetes renal insufficiency pre-existing liver or significant other disease other than NAFLD (i.e. autoimmune, viral or drug-induced liver disease) excessive use of alcohol (over 20g/day) pregnancy or lactation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sanja Sadevirta, MD
Phone
+358 9 471 71886
Email
sanja.sadevirta@hus.fi
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hannele Yki-Jarvinen, FRCP
Organizational Affiliation
Department of Medicine, Divisions of Diabetes2, Helsinki University Central Hospital, Helsinki, Finland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinical studies: Biomedicum 2U, Tukholmankatu 8, 00290 Helsinki, Rooms 106b and 105b
City
Helsinki
ZIP/Postal Code
00290
Country
Finland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anne Salo, Study nurse
Email
anne.salo@hus.fi
First Name & Middle Initial & Last Name & Degree
Sanja Sadevirta, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
34470478
Citation
Ruuth M, Lahelma M, Luukkonen PK, Lorey MB, Qadri S, Sadevirta S, Hyotylainen T, Kovanen PT, Hodson L, Yki-Jarvinen H, Oorni K. Overfeeding Saturated Fat Increases LDL (Low-Density Lipoprotein) Aggregation Susceptibility While Overfeeding Unsaturated Fat Decreases Proteoglycan-Binding of Lipoproteins. Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2823-2836. doi: 10.1161/ATVBAHA.120.315766. Epub 2021 Sep 2.
Results Reference
derived
PubMed Identifier
32536582
Citation
Jian C, Luukkonen P, Sadevirta S, Yki-Jarvinen H, Salonen A. Impact of short-term overfeeding of saturated or unsaturated fat or sugars on the gut microbiota in relation to liver fat in obese and overweight adults. Clin Nutr. 2021 Jan;40(1):207-216. doi: 10.1016/j.clnu.2020.05.008. Epub 2020 May 16.
Results Reference
derived
PubMed Identifier
29844096
Citation
Luukkonen PK, Sadevirta S, Zhou Y, Kayser B, Ali A, Ahonen L, Lallukka S, Pelloux V, Gaggini M, Jian C, Hakkarainen A, Lundbom N, Gylling H, Salonen A, Oresic M, Hyotylainen T, Orho-Melander M, Rissanen A, Gastaldelli A, Clement K, Hodson L, Yki-Jarvinen H. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars. Diabetes Care. 2018 Aug;41(8):1732-1739. doi: 10.2337/dc18-0071. Epub 2018 May 29.
Results Reference
derived

Learn more about this trial

Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue Inflammation

We'll reach out to this number within 24 hrs